Patent ID: 8088377

Claim:
An isolated monoclonal antibody which binds to human CD30, wherein the antibody comprises a heavy chain variable region comprising CDR1, CDR2, and CDR3 sequences and a light chain variable region comprising CDR1, CDR2, and CDR3 sequences, wherein (a) the heavy chain variable region comprises CDR1, CD2, and CDR3 sequences as set forth in SEQ ID NOs: 16, 17, and 18, respectively, and the light chain variable region comprises CDR1, CDR2, and CDR3 sequences as set forth in SEQ ID NOs: 22, 23, and 24, respectively, (b) the heavy chain variable region comprises CDR1, CD2, and CDR3 sequences as set forth in SEQ ID NOs: 28, 29, and 30, respectively, and the light chain variable region comprises CDR1, CDR2, and CDR3 sequences as set forth in SEQ ID NOs: 34, 35, and 36, respectively, or (c) the heavy chain variable region comprises CDR1, CD2, and CDR3 sequences as set forth in SEQ ID NOs: 40, 41, and 42, respectively, and the light chain variable region comprises CDR1, CDR2, and CDR3 sequences as set forth in SEQ ID NOs: 46, 47, and 48, respectively.